| |
| |
|
| Insider
Information: |
Baker Darryl S |
| Relationship: |
Chief Financial Officer |
| City: |
Scottsdale |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
198,375 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$769 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
198,375 |
|
|
| Total
Value |
$769 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
IGO Inc |
IGOI |
Chief Financial Office... |
2012-03-19 |
180,063 |
|
0 |
Premium* |
|
|
Insys Therapeutics, Inc. |
INSY |
Chief Financial Officer |
2016-11-10 |
18,312 |
2014-01-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2016-11-10 |
5 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
18,312 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2016-05-23 |
4 |
OE |
$13.57 |
$135,700 |
D/D |
10,000 |
21,030 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-11-20 |
5 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
11,030 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-05-18 |
4 |
AS |
$58.83 |
$591,720 |
D/D |
(10,000) |
9,377 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-02-09 |
4 |
AS |
$52.18 |
$456,714 |
D/D |
(8,752) |
19,377 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-02-09 |
4 |
OE |
$7.26 |
$63,540 |
D/D |
8,752 |
28,129 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-02-06 |
4 |
OE |
$2.36 |
$80,760 |
D/D |
21,248 |
40,625 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2015-02-06 |
4 |
AS |
$52.25 |
$1,110,250 |
D/D |
(21,248) |
19,377 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-05-15 |
4 |
OE |
$7.26 |
$72,600 |
D/D |
10,000 |
14,687 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Officer |
– – – |
2014-01-16 |
144 |
NP |
$0.00 |
$450,000 |
/ |
10,000 |
0 |
|
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-16 |
4 |
OE |
$10.89 |
$108,900 |
D/D |
10,000 |
13,125 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Officer |
– – – |
2014-01-16 |
144 |
NP |
$0.00 |
$225,000 |
/ |
5,000 |
0 |
|
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-16 |
4 |
AS |
$49.05 |
$496,126 |
D/D |
(10,000) |
3,125 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-15 |
4 |
AS |
$48.01 |
$240,058 |
D/D |
(5,000) |
3,125 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-15 |
4 |
OE |
$3.54 |
$17,700 |
D/D |
5,000 |
8,125 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-14 |
4 |
OE |
$3.54 |
$14,454 |
D/D |
4,083 |
7,208 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-14 |
4 |
AS |
$46.01 |
$187,878 |
D/D |
(4,083) |
3,125 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-14 |
4 |
OE |
$3.54 |
$17,700 |
D/D |
5,000 |
8,125 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-14 |
4 |
AS |
$47.07 |
$235,350 |
D/D |
(5,000) |
3,125 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Officer |
– – – |
2014-01-14 |
144 |
NP |
$0.00 |
$266,265 |
/ |
5,917 |
0 |
|
- |
|
| INSY |
Insys Therapeutics, Inc. |
Officer |
– – – |
2014-01-14 |
144 |
NP |
$0.00 |
$408,735 |
/ |
9,083 |
0 |
|
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-13 |
4 |
OE |
$3.54 |
$20,946 |
D/D |
5,917 |
9,042 |
0 |
- |
|
| INSY |
Insys Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2014-01-13 |
4 |
AS |
$45.25 |
$268,483 |
D/D |
(5,917) |
3,125 |
0 |
- |
|
| IGOI |
IGO Inc |
Chief Financial OfficerVice Pr |
• – – |
2012-03-19 |
4 |
D |
$0.65 |
$6,774 |
D/D |
(10,422) |
180,063 |
0 |
- |
|
| IGOI |
IGO Inc |
Chief Financial OfficerVice Pr |
• – – |
2011-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,000 |
190,485 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
